MRNA
Moderna, Inc. · Healthcare
Director Noubar Afeyan sold $40.9M of Moderna, Inc.
Sold$40,855,186
$131.79Price
310,000Shares
−2%Stake
What MRNA did after the filing
- The stock from Mon, May 16 open, $135.87
- +5.1%
- S&P 500, same days
- −4.5%
Measured over 30 trading days, to the Jun 29 close.
Traded Wed, May 11. Filed Fri, May 13. Returns use the May 16 open and the Jun 29 close. Not investment advice.